NCT07501416 High-Intensity Laser Therapy in Hemiplegic Shoulder Pain
| NCT ID | NCT07501416 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Kutahya Health Sciences University |
| Condition | Hemiplegia and/or Hemiparesis Following Stroke |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-04-01 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-04-01 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized, sham-controlled clinical trial aims to evaluate the effectiveness of high-intensity laser therapy (HILT) combined with exercise on pain, functional status, disability, and ultrasonographic findings in patients with hemiplegic shoulder pain following stroke.
Eligibility Criteria
Inclusion Criteria: * Age 30-75 years * Hemiplegic shoulder pain after stroke * Stroke within last 6 months * VAS ≥ 3 for pain * Medically stable Exclusion Criteria: * Neurological disorders (MS, Parkinson, etc.) * Recent shoulder surgery/injection * Botulinum toxin (last 6 months) * Malignancy * Pregnancy * Epilepsy or photosensitivity * Cognitive impairment
Contact & Investigator
Fatima YAMAN, Assoc. Prof.
PRINCIPAL INVESTIGATOR
Kutahya Health Sciences University
Frequently Asked Questions
Who can join the NCT07501416 clinical trial?
This trial is open to participants of all sexes, aged 30 Years or older, up to 75 Years, studying Hemiplegia and/or Hemiparesis Following Stroke. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07501416 currently recruiting?
Yes, NCT07501416 is actively recruiting participants. Contact the research team at alicagtay.dayi@ogr.ksbu.edu.tr for enrollment information.
Where is the NCT07501416 trial being conducted?
This trial is being conducted at Kütahya, Turkey (Türkiye).
Who is sponsoring the NCT07501416 clinical trial?
NCT07501416 is sponsored by Kutahya Health Sciences University. The principal investigator is Fatima YAMAN, Assoc. Prof. at Kutahya Health Sciences University. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.